LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 22

Search options

  1. Article ; Online: Genetic IL-6R variants and therapeutic inhibition of IL-6 receptor signalling in COVID-19 - Authors' reply.

    Bovijn, Jonas / Lindgren, Cecilia M / Holmes, Michael V

    The Lancet. Rheumatology

    2020  Volume 3, Issue 2, Page(s) e97–e98

    Language English
    Publishing date 2020-12-15
    Publishing country England
    Document type Journal Article
    ISSN 2665-9913
    ISSN (online) 2665-9913
    DOI 10.1016/S2665-9913(20)30415-X
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Genetic variants mimicking therapeutic inhibition of IL-6 receptor signaling and risk of COVID-19.

    Bovijn, Jonas / Lindgren, Cecilia M / Holmes, Michael V

    The Lancet. Rheumatology

    2020  Volume 2, Issue 11, Page(s) e658–e659

    Keywords covid19
    Language English
    Publishing date 2020-09-25
    Publishing country England
    Document type Journal Article
    ISSN 2665-9913
    ISSN (online) 2665-9913
    DOI 10.1016/S2665-9913(20)30345-3
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Colocalization analysis of polycystic ovary syndrome to identify potential disease-mediating genes and proteins.

    Censin, Jenny C / Bovijn, Jonas / Holmes, Michael V / Lindgren, Cecilia M

    European journal of human genetics : EJHG

    2021  Volume 29, Issue 9, Page(s) 1446–1454

    Abstract: Polycystic ovary syndrome (PCOS) is a common complex disease in women with a strong genetic component and downstream consequences for reproductive, metabolic and psychological health. There are currently 19 known PCOS risk loci, primarily identified in ... ...

    Abstract Polycystic ovary syndrome (PCOS) is a common complex disease in women with a strong genetic component and downstream consequences for reproductive, metabolic and psychological health. There are currently 19 known PCOS risk loci, primarily identified in women of Han Chinese or European ancestry, and 14 of these risk loci were identified or replicated in a genome-wide association study of PCOS performed in up to 10,074 cases and 103,164 controls of European descent. However, for most of these loci the gene responsible for the association is unknown. We therefore use a Bayesian colocalization approach (Coloc) to highlight genes in PCOS-associated regions that may have a role in mediating the disease risk. We evaluated the posterior probabilities of evidence consistent with shared causal variants between 14 PCOS genetic risk loci and intermediate cellular phenotypes in one protein (N = 3301) and two expression quantitative trait locus datasets (N = 31,684 and N = 80-491). Through these analyses, we identified seven proteins or genes with evidence of a possibly shared causal variant for almost 30% of known PCOS signals, including follicle stimulating hormone and ERBB3, IKZF4, RPS26, SUOX, ZFP36L2, and C8orf49. Several of these potential effector proteins and genes have been implicated in the hypothalamic-pituitary-gonadal signalling pathway and provide an avenue for functional follow-up in order to demonstrate a causal role in PCOS pathophysiology.
    MeSH term(s) Female ; Humans ; Ikaros Transcription Factor/genetics ; Oxidoreductases Acting on Sulfur Group Donors/genetics ; Polycystic Ovary Syndrome/genetics ; Polycystic Ovary Syndrome/metabolism ; Proteome/genetics ; Proteome/metabolism ; Quantitative Trait Loci ; Receptor, ErbB-3/genetics ; Ribosomal Proteins/genetics ; Transcription Factors/genetics
    Chemical Substances IKZF4 protein, human ; Proteome ; RPS26 protein, human ; Ribosomal Proteins ; Transcription Factors ; ZFP36L2 protein, human ; Ikaros Transcription Factor (148971-36-2) ; Oxidoreductases Acting on Sulfur Group Donors (EC 1.8.-) ; SUOX protein, human (EC 1.8.3.1) ; ERBB3 protein, human (EC 2.7.10.1) ; Receptor, ErbB-3 (EC 2.7.10.1)
    Language English
    Publishing date 2021-03-04
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 1141470-4
    ISSN 1476-5438 ; 1018-4813
    ISSN (online) 1476-5438
    ISSN 1018-4813
    DOI 10.1038/s41431-021-00835-8
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Genetically predicted vitamin K levels and risk of osteoarthritis: Mendelian randomization study.

    Zhao, Sizheng Steven / Bovijn, Jonas / Hughes, David M / Sha, Tinting / Zeng, Chao / Lyu, Houchen

    Seminars in arthritis and rheumatism

    2022  Volume 55, Page(s) 152030

    Abstract: Objective: Osteoarthritis (OA) is a progressive disease for which there is no disease modifying therapy. Vitamin K levels and vitamin K antagonism have been associated with risk and progression of OA which may have direct implications for clinical ... ...

    Abstract Objective: Osteoarthritis (OA) is a progressive disease for which there is no disease modifying therapy. Vitamin K levels and vitamin K antagonism have been associated with risk and progression of OA which may have direct implications for clinical management, but these observational findings are susceptible to confounding. We aimed to estimate the causal association between vitamin K and OA risk using Mendelian randomisation (MR).
    Methods: We used data from the largest genome-wide association study (GWAS) of OA to date (up to 826,690 individuals) to estimate the effect of genetically predicted vitamin K level (instrumented using four variants derived from a GWAS of 2,138 individuals) on risk of all OA types, knee, hip, spine, hand OA, and total joint replacement. We employed the inverse-variance weighted method for the primary analysis and, in a series of sensitivity analyses, adjusted for sub-genome wide significant instruments and tested for potential bias from pleiotropy.
    Results: We showed that genetically predicted vitamin K levels were not causally associated with risk of OA overall (OR 0.98 per unit increase in log-transformed vitamin K1; 95%CI 0.96-1.01), knee (OR 0.98; 0.92-1.03), hip (OR 0.97; 0.88-1.07), spine (OR 0.97; 0.90-1.04), hand OA (OR 0.97; 0.91-1.04) or joint replacement (OR 0.96; 0.89-1.04). Results were similar across all sensitivity analyses.
    Conclusion: We found little evidence of a causal association between genetically predicted vitamin K and OA risk. Larger genetic and interventional studies of vitamin K are required to confirm our findings.
    MeSH term(s) Genome-Wide Association Study ; Humans ; Mendelian Randomization Analysis ; Osteoarthritis/genetics ; Polymorphism, Single Nucleotide ; Vitamin K
    Chemical Substances Vitamin K (12001-79-5)
    Language English
    Publishing date 2022-05-24
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 120247-9
    ISSN 1532-866X ; 0049-0172
    ISSN (online) 1532-866X
    ISSN 0049-0172
    DOI 10.1016/j.semarthrit.2022.152030
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Commentary: Using human genetics to guide the repurposing of medicines.

    Bovijn, Jonas / Censin, Jenny C / Lindgren, Cecilia M / Holmes, Michael V

    International journal of epidemiology

    2020  Volume 49, Issue 4, Page(s) 1140–1146

    MeSH term(s) Alzheimer Disease ; Antihypertensive Agents ; Drug Repositioning ; Human Genetics ; Humans ; Mendelian Randomization Analysis
    Chemical Substances Antihypertensive Agents
    Language English
    Publishing date 2020-04-17
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Comment
    ZDB-ID 187909-1
    ISSN 1464-3685 ; 0300-5771
    ISSN (online) 1464-3685
    ISSN 0300-5771
    DOI 10.1093/ije/dyaa015
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Genetic variants mimicking therapeutic inhibition of IL-6 receptor signaling and risk of COVID-19

    Bovijn, Jonas / Lindgren, Cecilia M / Holmes, Michael V

    The Lancet Rheumatology

    2020  Volume 2, Issue 11, Page(s) e658–e659

    Keywords covid19
    Language English
    Publisher Elsevier BV
    Publishing country us
    Document type Article ; Online
    ISSN 2665-9913
    DOI 10.1016/s2665-9913(20)30345-3
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  7. Article ; Online: Commentary: Mendelian randomization and women's health.

    Censin, Jenny C / Bovijn, Jonas / Holmes, Michael V / Lindgren, Cecilia M

    International journal of epidemiology

    2019  Volume 48, Issue 3, Page(s) 830–833

    MeSH term(s) Breast Neoplasms ; Female ; Glucose ; Humans ; Insulin ; Mendelian Randomization Analysis ; Obesity ; Women's Health
    Chemical Substances Insulin ; Glucose (IY9XDZ35W2)
    Language English
    Publishing date 2019-07-10
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Comment
    ZDB-ID 187909-1
    ISSN 1464-3685 ; 0300-5771
    ISSN (online) 1464-3685
    ISSN 0300-5771
    DOI 10.1093/ije/dyz141
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Genetic inhibition of interleukin-6 receptor signaling and Covid-19

    Bovijn, Jonas / Lindgren, Cecilia M. / Holmes, Michael V.

    medRxiv

    Abstract: There are few effective therapeutic options for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Early evidence has suggested that IL-6R blockers may confer benefit, particularly in severe coronavirus disease 2019 ( ...

    Abstract There are few effective therapeutic options for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Early evidence has suggested that IL-6R blockers may confer benefit, particularly in severe coronavirus disease 2019 (Covid-19). We leveraged large-scale human genetic data to investigate whether IL6-R blockade may confer therapeutic benefit in Covid-19. A genetic instrument consisting of seven genetic variants in or close to IL6R was recently shown to be linked to altered levels of c-reactive protein (CRP), fibrinogen, circulating IL-6 and soluble IL-6R, concordant to known effects of pharmacological IL-6R blockade. We investigated the effect of these IL6R variants on risk of hospitalization for Covid-19 and other SARS-CoV-2-related outcomes using data from The Covid-19 Host Genetics Initiative. The IL6R variants were strongly associated with serum CRP levels in UK Biobank. Meta-analysis of scaled estimates revealed a lower risk of rheumatoid arthritis (OR 0.93 per 0.1 SD lower CRP, 95% CI, 0.90-0.96, P = 9.5 × 10<sup>-7</sup>), recapitulating this established indication for IL-6R blockers (e.g. tocilizumab and sarilumab). The IL-6R instrument was associated with lower risk of hospitalization for Covid-19 (OR 0.88 per 0.1 SD lower CRP, 95% CI, 0.78-0.99, P = 0.03). We found a consistent association when using a population-based control group (i.e. all non-cases; OR 0.91 per 0.1 SD lower CRP, 95% CI, 0.87-0.96, P = 4.9 × 10<sup>-4</sup>). Evaluation of further SARS-CoV-2-related outcomes suggested association with risk of SARS-CoV-2 infection, with no evidence of association with Covid-19 complicated by death or requiring respiratory support. We performed several sensitivity analyses to evaluate the robustness of our findings. Our results serve as genetic evidence for the potential efficacy of IL-6R blockade in Covid-19. Ongoing large-scale RCTs of IL-6R blockers will be instrumental in identifying the settings, including stage of disease, in which these agents may be effective.
    Keywords covid19
    Language English
    Publishing date 2020-07-19
    Publisher Cold Spring Harbor Laboratory Press
    Document type Article ; Online
    DOI 10.1101/2020.07.17.20155242
    Database COVID19

    Kategorien

  9. Article ; Online: Converging evidence from exome sequencing and common variants implicates target genes for osteoporosis.

    Zhou, Sirui / Sosina, Olukayode A / Bovijn, Jonas / Laurent, Laetitia / Sharma, Vasundhara / Akbari, Parsa / Forgetta, Vincenzo / Jiang, Lai / Kosmicki, Jack A / Banerjee, Nilanjana / Morris, John A / Oerton, Erin / Jones, Marcus / LeBlanc, Michelle G / Idone, Vincent / Overton, John D / Reid, Jeffrey G / Cantor, Michael / Abecasis, Goncalo R /
    Goltzman, David / Greenwood, Celia M T / Langenberg, Claudia / Baras, Aris / Economides, Aris N / Ferreira, Manuel A R / Hatsell, Sarah / Ohlsson, Claes / Richards, J Brent / Lotta, Luca A

    Nature genetics

    2023  Volume 55, Issue 8, Page(s) 1277–1287

    Abstract: In this study, we leveraged the combined evidence of rare coding variants and common alleles to identify therapeutic targets for osteoporosis. We undertook a large-scale multiancestry exome-wide association study for estimated bone mineral density, which ...

    Abstract In this study, we leveraged the combined evidence of rare coding variants and common alleles to identify therapeutic targets for osteoporosis. We undertook a large-scale multiancestry exome-wide association study for estimated bone mineral density, which showed that the burden of rare coding alleles in 19 genes was associated with estimated bone mineral density (P < 3.6 × 10
    MeSH term(s) Humans ; Genetic Predisposition to Disease ; Exome Sequencing ; Osteoporosis/genetics ; Bone Density/genetics ; Alleles ; Transcription Factors/genetics ; Genome-Wide Association Study
    Chemical Substances Transcription Factors
    Language English
    Publishing date 2023-08-09
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1108734-1
    ISSN 1546-1718 ; 1061-4036
    ISSN (online) 1546-1718
    ISSN 1061-4036
    DOI 10.1038/s41588-023-01444-5
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top